VEGFA and diabetic kidney disease: Using bioinformatics tools, FF has been previously predicted to increase VEGFA expression in diabetic nephropathy [39], while the drug has been shown to increase VEGFA levels in the visceral adipose tissue of FF-treated normolipemic rabbits [40].